This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Piercy R, Swardson C, Hinchcliff K (1998) Erythroid hypoplasia and anemia following administration of recombinant human erythropoietin to two horses. J Am Vet Med Assoc 212: 244–247
Coscarella A, Liddi R, Di LM, Bach S, Faiella A, van der Meide PH, Mele A, De Santis R (1998) The rhGM-CSF-EPO hybrid protein MEN 11300 induces anti-EPO antibodies and severe anaemia in rhesus monkeys. Cytokine 10: 964–969
Casadevall N, Nataf J, Viron B, Kolta A, Kiladjian JJ, Martin-Dupont P, Michaud P, Papo T, Ugo V, Teyssandier I et al. (2002) Pure red-cell aplasia and anti-erythropoietin antibodies in patients treated with recombinant erythropoietin. N Engl J Med 346: 469–475
Sytkowski A, Feldman L, Zurbuch D (1991) Biological activity and structural stability of N-deglycosylated recombinant human erythropoietin. Biochem Biophys Res Commun 176: 698–704
Delorme E, Lorenzini T, Giffin J, Martin F, Jacobsen F, Boone T, Elliott S (1992) Role of glycosylation on the secretion and biological activity of erythropoietin. Biochemistry 31: 9871–9876
Syed RS, Reid SW, Li C, Cheetham JC, Aoki KH, Liu B, Zhan H, Osslund TD, Chirino AJ, Zhang J et al. (1998) Efficiency of signalling through cytokine receptors depends critically on receptor orientation. Nature 395: 511–516
Skibeli V, Nissen-Lie G, Torjesen P (2001) Sugar profiling proves that human serum erythropoietin differs from recombinant human erythropoietin. Blood 98: 3626–3634
Casadevall N, Dupuy E, Molho-Sabatier P, Tobelem G, Varet B, Mayeux P (1996) Auto-antibodies against erythropoietin in a patient with pure red-cell aplasia. N Engl J Med 334: 630–633
Komatsu N, Nakauchi H, Miwa A, Ishihara T, Eguchi M, Moroi M, Okada M, Sato Y, Wada H, Yawata Y (1991) Establishment and characterization of a human leukemic cell line with megakaryocytic features: Dependency on granulocyte-macrophage colony stimulating factor, interleukin 3, or erythropoietin for growth and survival. Cancer Res 51: 341–348
Castelli G, Famularo A, Semino C, Machi A, Ceci A, Cannella G, Melioli G (2000) Detection of anti-erythropoietin antibodies in haemodialysis patients treated with recombinant human-erythropoietin. Pharmacol Res 41: 313–318
Urra JM, de la Torre M, Alcazar R, Peces R (1997) Rapid method for detection of anti-recombinant human erythropoietin antibodies as a new form of erythropoietin resistance. Clin Chem 43: 848–849
Prabhakar S, Muhlfelder T (1997) Antibodies to recombinant human erythropoietin causing pure red cell aplasia. Clin Nephrol 47: 331–335
Linardaki GD, Boki KA, Fertakis A, Tzioufas AG (1999) Pure red cell aplasia as presentation of systemic lupus erythematosus: Antibodies to erythropoietin. Scand. J Rheumatol 28: 189–191
Peschle C, Marmont AM, Marone G, Genovese A, Sasso GF, Condorelli M (1975) Pure red cell aplasia: Studies on an IgG serum inhibitor neutralizing erythropoietin. Br J Haematol 30: 411–417
Marmont A, Peschle C, Sanguineti M, Condorelli M (1975) Pure red cell aplasia (PRCA): Response of three patients of cyclophosphamide and/or antilymphocyte globulin (ALG) and demonstration of two types of serum IgG inhibitors to erythropoiesis. Blood 45: 247–261
Bergrem H, Danielson BG, Eckardt KU, Kurtz A, Strisberg M (1993) A case of anti-erythropoietin antibodies following recombinant human erythropoietin treatment. In: C Bauer, KM Koch, P Scigalla, L Wieczorek (eds): Erythropietin: Molecular physiology and clinical application. Marcel Dekker, New-York, 266–275
Peces R, de la Torre M, Alcazar R, Urra JM (1996) Antibodies against recombinant human erythropoietin in a patient with erythropoietin-resistant anemia. N Engl J Med 335: 523–524
Pazur JH, Jensen PJ, Murray AK (2000) Oligosaccharides as immunodeterminants of erythropoietin for two sets of anti-carbohydrate antibodies. J Protein Chem 19: 631–635
Gershon SK, Luksenburg H, Cote TR, Braun MM (2002) Pure red-cell aplasia and recombinant erythropoietin. N Engl J Med 346: 1584–1586
Voulgari PV, Hatzimichael EC, Tsiara S, Tzallas C, Drosos AA, Bourantas KL (2001) Investigation for the presence of anti-erythropoietin antibodies in patients with myelodysplastic syndromes. Eur J Haematol 66: 31–36
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Birkhüser Verlag/Switzerland
About this chapter
Cite this chapter
Mayeux, P., Casadevall, N. (2003). Antibodies to endogenous and recombinant erythropoietin. In: Molineux, G., Foote, M.A., Elliott, S.G. (eds) Erythropoietins and Erythropoiesis. Milestones in Drug Therapy MDT. Birkhäuser Basel. https://doi.org/10.1007/3-7643-7543-4_14
Download citation
DOI: https://doi.org/10.1007/3-7643-7543-4_14
Publisher Name: Birkhäuser Basel
Print ISBN: 978-3-7643-7542-3
Online ISBN: 978-3-7643-7543-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)